Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Inclusion body myositis
ADR ID BADD_A10159
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.05      Muscular autoimmune disorders
10.04.05.011      Inclusion body myositis
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.01      Muscle infections and inflammations
15.05.01.013      Inclusion body myositis
Description Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10) [MeSH]
MedDRA Code 10066407
MeSH ID D018979
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Inclusion body myositis | Sporadic inclusion body myositis | Myositis, Inclusion Body | Inclusion Body Myositides | Myositides, Inclusion Body | Inclusion Body Myositis | Inclusion Body Myopathy, Sporadic | Myositis, Inclusion Body, Sporadic | Myopathy, Inclusion Body, Sporadic | Inclusion Body Myositis, Sporadic | Sporadic Inclusion Body Myositis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01325Lovastatin0.000042%
The 1th Page    1    Total 1 Pages